Latest Profitability Outlook News

Monash IVF Group has lowered its full-year profit guidance for FY2025 to $27.5 million, citing weaker market conditions and ongoing impacts from a recent operational incident in Brisbane. The company remains cautious as it monitors patient trends and legal costs.

Australian Wealth Advisors Group (AWAG) has completed strategic investments in Oneledger Group and B2B Invest, positioning itself for a net profit before tax exceeding $900k in 2026.

Alliance Aviation Services has updated its FY25 financial guidance, aiming for EBITDA between $205-210 million while navigating operational disruptions and planning significant debt reduction by 2026.

Vitura Health reports sustained revenue and EBITDA growth in Q3 FY2025, driven by recent acquisitions and operational improvements, positioning the company well for FY2026.

Judo Capital Holdings clarifies its recent Q3 financial disclosures, affirming compliance with ASX rules while highlighting FY26 profit guidance as material information.

Platinum Investment Management's Funds Under Management fell to $9.65 billion in April amid market pressures and retail outflows, while a major $958 million institutional mandate termination prompts accelerated cost savings.

Woolworths Group reported a 3.2% rise in total sales to $17.3 billion for Q3 FY2025, driven by strong growth in Australian Food, B2B, and New Zealand segments, alongside a 15.7% surge in eCommerce. However, BIG W’s sales decline and profit outlook challenges temper the overall performance.

XPON Technologies reported a modest 1% quarter-on-quarter revenue increase to $2.09 million in Q3 FY25, driven by a strong 87% recurring revenue base and a 75% gross margin. The company extended its convertible note maturity and is focused on recalibrating sales and accelerating AI innovation.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

Tower Limited has raised its FY25 underlying NPAT guidance to $70m–$80m, citing better-than-expected claims experience and favorable weather, while revising premium growth and expense ratio forecasts.

SRG Global has reported a record first half for FY25, posting a 21% revenue increase and upgrading its full-year profit guidance, driven by strong cash flow and successful integration of the Diona acquisition.

Kina Securities confirms its 2024 underlying profit guidance amid a non-cash statutory profit reduction driven by deferred tax asset adjustments and a customer fraud impact.